Neogen Corporation operates in the Diagnostic substances sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Neogen with three other
pharmaceutical manufacturers in North America:
sales of $563.00 million
of which 65%
Meridian Bioscience, Inc.
of which 71%
was US Diagnostics), and
of which 100%
Neogen reported sales of $361.59 million
May of 2017.
increase of 12.5%
versus 2016, when the company's sales were $321.28 million.
Sales at Neogen have increased during each of the previous five years
(and since 2012, sales have increased a total of 96%).
Sales of Food Safety saw an increase
17.5% in 2017, from
$145.84 million to $171.33 million.